omniture

China Pharma Holdings, Inc. Announces Conference Call to Discuss Third Quarter 2006 Results

China Pharma Holdings, Inc.
2006-11-09 11:58 1465


HAIKOU CITY, China, Nov. 8 /Xinhua-PRNewswire/ -- China Pharma Holdings,

Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the

Company will host a conference call at 10:00 am EST on Tuesday, November 14,

2006, to discuss results for the third quarter of 2006.

Joining Ms. Zhilin Li, President and CEO of China Pharma, will be Mr.

Xinhua Wu, Chief Financial Officer, and Mr. Donald Xu, Vice President,

Strategic Planning and Business Development. The Company plans to distribute

its earnings announcement earlier that same day.

To participate in the conference call, please dial the following number

five to ten minutes prior to the scheduled conference call time:

(888) 419-5570. International callers should dial (617) 896-9871. The

conference passcode is 66962583.

If you are unable to participate in the call at this time, a replay will

be available on Tuesday, November 14 at 12:00 am EST, through Tuesday,

November 21 at 12:00 am EST. To access the replay, dial (888) 286-8010.

International callers should dial (617) 801-6888. The conference passcode is

84660865.

This conference call will be broadcast live over the Internet and can be

accessed by all interested parties by clicking on

http://phx.corporate-ir.net/playerlink.zhtml?c=145098&s=wm&e=1414793. Please

access the link at least fifteen minutes prior to the start of the call to

register, download, and install any necessary audio software. For those unable

to participate during the live broadcast, a 90 day replay will be available

shortly after the call by accessing the same link.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic

and brand bio-pharmaceutical products in China that treat a wide range of

conditions, including infections, hepatitis, cardiovascular and CNS diseases,

and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson),

a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan

province in China, is a wholly owned subsidiary of China Pharma Holdings.

Safe Harbor Statement Under the Private Securities Litigation Reform Act

of 1995: Any statements set forth above that are not historical facts are

forward-looking statements that involve risks and uncertainties that could

cause actual results to differ materially from those in the forward-looking

statements, which may include, but are not limited to, such factors as

unanticipated changes in product demand, increased competition, failure to

obtain or maintain intellectual property protection, downturns in the Chinese

economy, uncompetitive levels of research and development, failure to obtain

regulatory approvals, and other information detailed from time to time in the

Company's filings and future filings with the United States Securities and

Exchange Commission.

Source: China Pharma Holdings, Inc.
collection